QYR Market Research Global Medical Asparaginase market research | Page 4

QYResearch
• The classification of Medical Asparaginase includes Escherichia
coli, Erwinia Chrysanthemi and Pegylated, and the sales proportion
of Escherichia coli in 2017 is about 64.6%, and the proportion is
decreasing trend from 2013 to 2018.
• Medical Asparaginase is widely sales for Acute Lymphoblastic
Leukemia, Acute Myeloid Leukemia and Others. The most
proportion of Medical Asparaginase is sales in Acute Lymphoblastic
Leukemia, and the consumption proportion is about 90% in 2017.
www.qyresearch.com